Source: Annual Congress 2006 - COPD – therapy/exacerbations
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Mishustina, T. Ageeva, S. Mishustin (Tomsk, Russian Federation). Gram-negative enterobacteria in the etiological structure of COPD exacerbation. Eur Respir J 2006; 28: Suppl. 50, 305

Member's Comments

No comment yet.

Related content which might interest you: The role of bacterial infections in COPD exacerbations Source: Eur Respir J 2005; 26: Suppl. 49, 298s Year: 2005 Etiology pathogens structure in community-acquired pneumonias and COPD exacerbations Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Pseudomonas aeruginosa drug susceptibility in patients hospitalized with COPD exacerbation and bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001 Pseudomonas aeruginosa and antibiotic resistance in acute exacerbations of COPD (AECOPD) Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa Year: 2009 Causative bacteria in protracted bacterial bronchitis are biofilm forming species Source: International Congress 2018 – Orphan diseases in children Year: 2018 Acute exacerbations of COPD due to pseudomonas aeruginosa: Impact of antimicrobial resistance Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 Bacterial infections in COPD Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases Year: 2008 What is bacterial colonisation in COPD? Source: Eur Respir Monogr 2015; 69: 161-171 Year: 2015 A study of exacerbations by Gram-negative organisms in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007 The role of bacteria in COPD exacerbations Source: International Congress 2014 – PG04 Update on COPD exacerbations Year: 2014 The impact of pseudomonas aeruginosa in the sputum of patients presenting with acute COPD exacerbation Source: Annual Congress 2004 - Role of infection in COPD Year: 2004 Community-acquired pneumonia in Europe: causative pathogens and resistance patterns Source: Eur Respir J 2002; 20: 20S-27S Year: 2002 Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015 The etiology and antimicrobial drugs resistance of microorganisms in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 2s Year: 2006 Epidemiology, treatment and outcomes of nosocomial pneumonia due to Gram-negative bacteria Source: Eur Respir J 2007; 30: Suppl. 51, 408s Year: 2007 Antibiotics reduce dual pathogen isolates more than single pathogen isolates following COPD exacerbation Source: Annual Congress 2009 - Exacerbations of COPD: new findings Year: 2009 The role of bronchial bacterial infection/colonization in acute exacerbation of COPD Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Evolution of antimicrobial susceptibility of respiratory isolates in chronic obstructive pulmonary patients diagnosed of acquired community pneumonia Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Bacterial infections in patients with acute exacerbations of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 639s Year: 2004 Structure of the basic pathogens of bacterial bronchitis and pneumonia in hospitalized patients in Belarus Source: Eur Respir J 2006; 28: Suppl. 50, 4s Year: 2006